Boston Scientific
Trade Boston Scientific 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BSX
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
BSX Key Statistics
Stock Snapshot
As of today, Boston Scientific(BSX) shares are valued at $63.28. The company's market cap stands at 93.1B, with a P/E ratio of 32.36.
During the trading session on 2026-04-01, Boston Scientific(BSX) shares reached a daily high of $63.28 and a low of $62.75. At a current price of $63.28, the stock is +0.9% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 4.93K, compared to an average daily volume of 17.66M.
Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $61.25.
Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $61.25.
BSX News
Boston Scientific (BSX) projected strong growth. They said their heart-device technology was gaining share in the market. Investors were told the momentum would...
If you are wondering whether Boston Scientific at around US$62.93 still offers value, the key question is how its current price lines up with the cash flows and...
Boston Scientific (NYSE:BSX), a maker of medical devices for interventional specialties, closed Monday at $62.92, down 9.03%. The stock moved lower on Monday as...
Analyst ratings
97%
of 37 ratingsMore BSX News
Feature Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data. In this article BSX SPX Boston Scientific stock was on pace for i...
According to a regulatory filing, Penumbra (PEN) and Boston Scientific (BSX) each filed a notification and report form under the HSR Act with the DOJ and the FT...
WATCHMAN FLX Shows Bleeding Advantage, Matches Efficacy The CHAMPION-AF study results shared on Saturday highlighted the WATCHMAN FLX device’s efficacy compare...
Wells Fargo says that while Boston Scientific’s (BSX) CHAMPION-AF trial met its endpoints, the data is unlikely to accelerate Watchman growth given a slightly h...
Analyst Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific and keeping the price target at $100.00. Unlock hedge fund-level data and powe...
Boston Scientific (BSX) announced that the Champion-AF global clinical trial met all primary and secondary safety and efficacy endpoints. The study evaluated th...
Boston Scientific (BSX) stock has come under pressure after a class action lawsuit accused the company of misleading investors about its Electrophysiology growt...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.